rs1216352 - LINC03140 - JADRR
Magnitude 4.5 · 1 study on file
Reported associations
-
Genome-wide association study of the plasma triglyceride response to an n-3 polyunsaturated fatty acid supplementation. - Journal of lipid research (2018) · Rudkowska I, Guénard F, Julien P, Couture P, Lemieux S, Barbier O, Calder PC, Minihane AM, Vohl MC · PubMed 24847101
Studies have shown a large interindividual variability in plasma TG response to long-chain n-3 PUFA supplementation, which may likely be attributable to genetic variability within the populations studied. The objective is to compare the frequency of SNPs in a genome-wide association study between responders (reduction in plasma TG levels ≥0.01 mM) and nonresponders (increase in plasma TG of ≥0 mM) to supplementation. Genomic DNA from 141 subjects who completed a 2-week run-in period followed by 6-week supplementation with 5 g of fish oil daily (1.9-2.2 g EPA and 1.1 g DHA daily) were genotyped on Illumina HumanOmni-5-QuadBeadChip. Thirteen loci had frequency differences between responders and nonresponders (P < 1 × 10(-5)), including SNPs in or near IQCJ-SCHIP1, MYB, NELL1, NXPH1, PHF
Auto-generated from study metadata. AI-synthesised commentary is added when this entry is regenerated through content-service's LLM mode.
Lifestyle context
Concrete actions anchored to the cited research. We do not prescribe, we describe.
Supplements
-
long-chain omega-3 (fish oil) supplementation Moderate
Variant associated with individual differences in triglyceride response to long-chain n-3 PUFA supplementation.
If considering for elevated triglycerides, monitor lipid panel 4-8 weeks after starting dose